Skip to main content

Table 2 Function of LINC01133 in animal models

From: A review on the role of LINC01133 in cancers

Tumor/disorder type

Animal models

Results

References

Gastric cancer

Immunodeficient BABL/c female nude mice

↑ LINC01133: ↓ GC progression and ↓ metastasis

[21]

Tumor-bearing nude mice

↑ LINC01133: ↓ tumor growth

[22]

Epithelial ovarian cancer

Female athymic BALB/c nude mice

↑ LINC01133: ↑ metastasis

[14]

Ovarian cancer

Female BALB/c nude mice

∆ LINC01133: ↑ tumor weight, ↑ tumor volume, ↑ metastasis

[15]

Hepatocellular carcinoma

Female BALB/c nude mice

∆ LINC01133: ↓ tumor weight, ↓ PI3K/AKT signaling activity

[23]

Male BALB/c nu/nu mice

↑ LINC01133: ↑ tumor volume, ↑ metastasis

[19]

Breast cancer

Female nude mice

∆ LINC01133: ↑ metastasis

[25]

Nasopharyngeal carcinoma

Immunodeficient male BALB/c nude mice

↑ LINC01133: ↓ metastasis

[26]

Renal cell carcinoma

Female nude BALB/7 mice

∆ LINC01133: ↓ tumor weight, ↓ tumor volume

[27]

Pancreatic cancer

BALB/c nude mice

∆ LINC01133: ↓ tumor weight, ↓ proliferation

[29]

Male BALB/c-nu nude mice

↑ LINC01133: ↑ tumor weight, ↑ metastasis

∆ LINC01133: ↓ tumor weight, ↓ metastasis

[18]

SCID mice

↑ miR-216a -5p

(a target of LINC01133): ↓ tumor weight, ↓ metastasis

[30]

Male immunodeficient BALB/c nude mice

∆ LINC01133: ↓ tumor growth, ↓ tumor weight and ↓ tumor volume

[31]

Colorectal cancer

Male NOD–SCID–gamma mice

∆ LINC01133: ↑ metastasis

[34]

Lung cancer

Female athymic BALB/c nude mice

∆ LINC01133: ↓ tumor weight, ↓ tumor growth

[20]

Bladder cancer

Male BALB/c-nu mice

↑ LINC01133: ↓ tumor growth

[36]

  1. ∆: knock-down or deletion, GC: Gastric cancer, SCID: severe combined immunodeficient